methamphetamine has been researched along with Degenerative Diseases, Central Nervous System in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 7 (28.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Graves, SM; Lee, YB | 1 |
| Ciccarone, D; Shoptaw, S | 1 |
| Chen, X; Hu, M; Tang, J; Tao, L; Wang, J; Wang, X; Zhang, X; Zhang, Y | 1 |
| Boontor, A; Govitrapong, P; Nopparat, C; Panmanee, J | 1 |
| Spector, SA; Teodorof-Diedrich, C | 1 |
| Alcaraz-Silva, J; Barberena, JJ; Budde, H; Imperatori, C; Machado, S; Murillo-Rodríguez, E; Quiroga, C; Telles-Correia, D; Yadollahpour, A; Yamamoto, T | 1 |
| Biagioni, F; Busceti, CL; Celli, R; Fornai, F; Limanaqi, F | 1 |
| Ares-Santos, S; Granado, N; Moratalla, R; Tizabi, Y | 1 |
| Ishige, K; Ito, Y; Kosuge, Y; Osada, N | 1 |
| Cho, HJ; Dang, DK; Hong, JS; Jang, CG; Jeong, JH; Kim, HC; Lee, J; Lee, JC; Nabeshima, T; Nam, Y; Nguyen, TT; Nguyen, XK; Park, DH; Shin, EJ | 1 |
| Cong, B; Gou, H; Li, M; Li, Y; Liu, L; Ma, C; Wen, D; Zhang, W | 1 |
| Asanuma, M; Miyazaki, I | 1 |
| Benkovic, SA; Miller, DB; O'Callaghan, JP; Sriram, K | 1 |
| Boonchoong, P; Kammasud, N; Sumanont, Y; Vajragupta, O; Watanabe, H; Wongkrajang, Y | 1 |
| Anderson, LI; Dluzen, DE; Laping, NJ; Tweed, C | 1 |
| Capobianco, L; De Blasi, A; Ferrucci, M; Fornai, F; Iacovelli, L; Lazzeri, G; Lenzi, P; Picascia, A | 1 |
| Fleckenstein, AE; Hanson, GR; Riddle, E; Sandoval, V | 1 |
| Ali, SF; Imam, SZ; Itzhak, Y | 1 |
| Binienda, Z; Gaetani, F; Virmani, A | 1 |
| Fleckenstein, AE; Hanson, GR; Volz, TJ | 1 |
| Cass, WA; Maragos, WF; Nath, A; Theodore, S | 1 |
| Abekawa, T; Fang, YR; Ito, K; Koyama, T; Li, XB | 1 |
| Brannock, C; Cadet, JL | 1 |
| Camarasa, J; Camins, A; Escubedo, E; Guitart, L; Jiménez, A; Pallàs, M; Pubill, D; Sureda, FX | 1 |
| Dryhurst, G | 1 |
10 review(s) available for methamphetamine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
The Role of Peroxisome Proliferator-Activated Receptor in Addiction: A Novel Drug Target.
Topics: Alcohols; Analgesics, Opioid; Behavior, Addictive; Cannabis; Cocaine; Humans; Ligands; Methamphetamine; Molecular Targeted Therapy; Neurodegenerative Diseases; Nicotine; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Pharmaceutical Preparations; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2021 |
Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders.
Topics: Autophagy; Dopamine; Humans; Methamphetamine; Neurodegenerative Diseases; Neuronal Plasticity; Neurotransmitter Agents | 2021 |
Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Endoplasmic Reticulum Stress; Hippocampus; Humans; Huntington Disease; Long-Term Potentiation; Methamphetamine; Mice; Molecular Targeted Therapy; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Plicamycin; Reperfusion Injury | 2013 |
Approaches to prevent dopamine quinone-induced neurotoxicity.
Topics: Animals; Dopamine; Humans; Methamphetamine; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders | 2009 |
Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Antioxidants; Carnitine; Central Nervous System Stimulants; Coenzymes; Energy Metabolism; Fatty Acids, Unsaturated; Glucose; Humans; Methamphetamine; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Ubiquinone | 2005 |
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Methamphetamine; Neurodegenerative Diseases; Neurotoxicity Syndromes; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2007 |
Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.
Topics: AIDS Dementia Complex; Amphetamine-Related Disorders; Basal Ganglia; Central Nervous System Stimulants; Dopamine Agents; Gene Products, tat; HIV Infections; HIV-1; Humans; Methamphetamine; Neurodegenerative Diseases; tat Gene Products, Human Immunodeficiency Virus | 2007 |
Free radicals and the pathobiology of brain dopamine systems.
Topics: Animals; Brain; Dopamine; Free Radicals; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 1998 |
Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; Dopamine; Dopamine Uptake Inhibitors; Glutathione; Humans; Methamphetamine; Nervous System; Neurodegenerative Diseases; Norepinephrine; Protein Precursors; Reperfusion Injury; Serotonin | 2001 |
15 other study(ies) available for methamphetamine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antioxidants; Calcium Channels, L-Type; Dopaminergic Neurons; Male; Methamphetamine; Mice; Mitochondria; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Pars Compacta; Ventral Tegmental Area | 2021 |
Methamphetamine-mediated dissemination of β-amyloid: Disturbances in endocytosis, transport and clearance of β-amyloid in microglial BV2 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Endocytosis; Humans; Methamphetamine; Microglia; Neurodegenerative Diseases; Peptide Fragments | 2022 |
Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Humans; Melatonin; Methamphetamine; Neuroblastoma; Neurodegenerative Diseases; Receptors, Melatonin | 2022 |
Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.
Topics: Cells, Cultured; Dynamins; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Methamphetamine; Microtubule-Associated Proteins; Mitochondria; Neurodegenerative Diseases; Neurons; Sequestosome-1 Protein; tat Gene Products, Human Immunodeficiency Virus | 2020 |
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.
Topics: Animals; Calcium-Binding Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; GAP-43 Protein; Glial Fibrillary Acidic Protein; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurodegenerative Diseases; Presynaptic Terminals; Psychomotor Disorders; Recovery of Function; Silver Staining; Time Factors; Tyrosine 3-Monooxygenase | 2018 |
Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.
Topics: Animals; Antioxidants; Apoptosis; Dopamine; Dopamine Uptake Inhibitors; Liposomes; Melatonin; Methamphetamine; Mice; Mice, Knockout; Mitochondria; Neurodegenerative Diseases; Protein Kinase C-delta | 2015 |
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Topics: Amphetamine-Related Disorders; Animals; Body Temperature; Cholecystokinin; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Peptide Fragments; Random Allocation; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
Obesity exacerbates chemically induced neurodegeneration.
Topics: Animals; Astrocytes; Brain; Disease Models, Animal; Dopamine; Female; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; Ion Channels; Kainic Acid; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Obese; Microtubule-Associated Proteins; Mitochondrial Proteins; Neostriatum; Neurodegenerative Diseases; Neurons; Neurotoxicity Syndromes; Neurotoxins; Obesity; Presynaptic Terminals; Proteins; Uncoupling Protein 2 | 2002 |
Manganese-based complexes of radical scavengers as neuroprotective agents.
Topics: Animals; Antioxidants; Brain; Brain Ischemia; Dopamine; Flavonoids; Free Radical Scavengers; In Vitro Techniques; Learning; Lipid Peroxidation; Manganese; Memory Disorders; Methamphetamine; Mice; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Organometallic Compounds; Superoxide Dismutase; Tacrine | 2003 |
Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system.
Topics: Animals; Dopamine; Female; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neostriatum; Neurodegenerative Diseases; Neurotoxins; RNA, Messenger; Sex Factors; Substantia Nigra | 2003 |
Presence of beta-arrestin in cellular inclusions in metamphetamine-treated PC12 cells.
Topics: Animals; Arrestins; beta-Arrestins; Central Nervous System Stimulants; Disease Models, Animal; Inclusion Bodies; Methamphetamine; Neurodegenerative Diseases; PC12 Cells; Rats; Signal Transduction; Time Factors; Ubiquitin | 2003 |
Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Methylphenidate; Neurodegenerative Diseases; Protein Transport; Rats; Rats, Sprague-Dawley; Vesicular Biogenic Amine Transport Proteins | 2004 |
Role of peroxynitrite in methamphetamine-induced dopaminergic neurodegeneration and neuroprotection by antioxidants and selective NOS inhibitors.
Topics: Animals; Antioxidants; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Indazoles; Methamphetamine; Mice; Mice, Knockout; Neurodegenerative Diseases; Neuroprotective Agents; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Peroxynitrous Acid | 2005 |
Effects of behavioral and neurochemical changes on adult excitotoxic lesion of the ventral hippocampus.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Hippocampus; Male; Methamphetamine; Motor Activity; Neurodegenerative Diseases; Neurotoxins; Rats; Rats, Sprague-Dawley; Schizophrenia | 2007 |
Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats.
Topics: Adenosine; Animals; Biological Transport; Carrier Proteins; Cerebellum; Corpus Striatum; Down-Regulation; Gliosis; Heat-Shock Proteins; Hippocampus; Male; Methamphetamine; Microglia; Neurodegenerative Diseases; Radioligand Assay; Rats; Rats, Sprague-Dawley | 1998 |